Efficacy of pemetrexed-based regimens in advanced non–small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic review

Efficacy of pemetrexed-based regimens in advanced non–small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic review

BaoHui Han,1 LuLu Yang,2 Xin Wang,3 LuanDi Yao2 1Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China; 2Lilly Suzhou Pharmaceutical Co. Ltd, Shanghai, People’s Republic of China; 3Asia Pacific Statistical...

Full description

Bibliographic Details
Main Authors: Han BH, Yang LL, Wang X, Yao LD
Format: Article
Language:English
Published: Dove Medical Press 2018-04-01
Series:OncoTargets and Therapy
Subjects:
Pemetrexed
Advanced non-small cell lung cancer
Epidermal growth factor receptor
Tyrosine kinase inhibitor
Online Access:https://www.dovepress.com/efficacy-of-pemetrexed-based-regimens-in-advanced-non-small-cell-lung--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/efficacy-of-pemetrexed-based-regimens-in-advanced-non-small-cell-lung--peer-reviewed-article-OTT

Similar Items